Top Pfizer, Moderna execs at odds on need for 4th COVID-19 vaccine dosenews2022-03-15T12:58:22+00:00March 15th, 2022|Fierce Pharma|
CDMO I Peace expansion triples capacity to manufacture induced pluripotent stem cellsnews2022-03-15T12:58:07+00:00March 15th, 2022|Fierce Pharma|
Biogen takes full control of troubled Aduhelm in revamped Eisai dealnews2022-03-15T10:49:06+00:00March 15th, 2022|Fierce Pharma|
Incyte’s Opzelura slapped with vitiligo delay amid topical JAK’s eczema launchnews2022-03-14T14:31:51+00:00March 14th, 2022|Fierce Pharma|
UsAgainstAlzheimer’s, spending millions to bat for Biogen’s Aduhelm, launches TV and digital campaignnews2022-03-14T13:28:40+00:00March 14th, 2022|Fierce Pharma|
AstraZeneca’s Fasenra hit with FDA rejection, falling further behind GSK’s Nucala in nasal polypsnews2022-03-14T13:22:10+00:00March 14th, 2022|Fierce Pharma|
Pfizer pledges to donate all Russian profits to humanitarian causes amid war in Ukrainenews2022-03-14T13:11:16+00:00March 14th, 2022|Fierce Pharma|
Novartis’ Sandoz bulks up in respiratory as strategic review of the generics outfit rolls onnews2022-03-14T12:29:01+00:00March 14th, 2022|Fierce Pharma|
AstraZeneca, Merck’s Lynparza snags first-in-class FDA nod for early breast cancernews2022-03-14T10:09:08+00:00March 14th, 2022|Fierce Pharma|
Get ready to vote: Fierce Pharma’s #FierceMadness drug name tournament is back for 2022news2022-03-14T09:00:27+00:00March 14th, 2022|Fierce Pharma|
